Peyrin-Biroulet L - Search Results

1

Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases.

Bouguen G, Chevaux JB, Peyrin-Biroulet L. Bouguen G, et al. World J Gastroenterol. 2011 Feb 7;17(5):547-56. doi: 10.3748/wjg.v17.i5.547. World J Gastroenterol. 2011. PMID: 21350703 Free PMC article. Review.

2

Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine.

Peyrin-Biroulet L, Rodriguez-Guéant RM, Chamaillard M, Desreumaux P, Xia B, Bronowicki JP, Bigard MA, Guéant JL. Peyrin-Biroulet L, et al. Am J Gastroenterol. 2007 May;102(5):1108-15. doi: 10.1111/j.1572-0241.2007.01170.x. Epub 2007 Mar 13. Am J Gastroenterol. 2007. PMID: 17355415 Review.

3

A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity.

Roblin X, Peyrin-Biroulet L, Phelip JM, Nancey S, Flourie B. Roblin X, et al. Am J Gastroenterol. 2008 Dec;103(12):3115-22. doi: 10.1111/j.1572-0241.2008.01743.x. Am J Gastroenterol. 2008. Retraction in: Am J Gastroenterol. 2009 Mar;104(3):801. doi: 10.1038/ajg.2009.101. PMID: 19086961 Retracted. Clinical Trial.

4

Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France.

Chevaux JB, Nani A, Oussalah A, Venard V, Bensenane M, Belle A, Gueant JL, Bigard MA, Bronowicki JP, Peyrin-Biroulet L. Chevaux JB, et al. Inflamm Bowel Dis. 2010 Jun;16(6):916-24. doi: 10.1002/ibd.21147. Inflamm Bowel Dis. 2010. PMID: 19885908

5

Nonfistulizing perianal Crohn's disease: clinical features, epidemiology, and treatment.

Bouguen G, Siproudhis L, Bretagne JF, Bigard MA, Peyrin-Biroulet L. Bouguen G, et al. Inflamm Bowel Dis. 2010 Aug;16(8):1431-42. doi: 10.1002/ibd.21261. Inflamm Bowel Dis. 2010. PMID: 20310013 Review.

6

Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy.

Oussalah A, Chevaux JB, Fay R, Sandborn WJ, Bigard MA, Peyrin-Biroulet L. Oussalah A, et al. Am J Gastroenterol. 2010 May;105(5):1142-9. doi: 10.1038/ajg.2010.158. Epub 2010 Apr 13. Am J Gastroenterol. 2010. PMID: 20389296

7

Herpes simplex virus colitis complicating the course of a patient with Crohn's disease and cirrhosis: an underestimated association?

Chevaux JB, Peyrin-Biroulet L. Chevaux JB, et al. Gastroenterol Hepatol (N Y). 2010 Feb;6(2):122-4. Gastroenterol Hepatol (N Y). 2010. PMID: 20567556 Free PMC article. No abstract available.

8

Acute hepatic cytolysis following H1N1 vaccination in a patient with Crohn's disease on infliximab.

Pillot C, Chevaux JB, Petitpain N, Peyrin-Biroulet L. Pillot C, et al. Inflamm Bowel Dis. 2011 Feb;17(2):679. doi: 10.1002/ibd.21321. Inflamm Bowel Dis. 2011. PMID: 20848494 No abstract available.

9

Optimizing thiopurine therapy in inflammatory bowel disease.

Chevaux JB, Peyrin-Biroulet L, Sparrow MP. Chevaux JB, et al. Inflamm Bowel Dis. 2011 Jun;17(6):1428-35. doi: 10.1002/ibd.21494. Epub 2010 Oct 14. Inflamm Bowel Dis. 2011. PMID: 20949566 Review.

10

Infliximab 10 mg/kg every 3 weeks for Crohn's disease.

Pillot C, Chevaux JB, Bigard MA, Peyrin-Biroulet L. Pillot C, et al. Am J Gastroenterol. 2010 Nov;105(11):2509-10. doi: 10.1038/ajg.2010.244. Am J Gastroenterol. 2010. PMID: 21048692 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,088 results

Search Page

Filters